GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (TSX:TH) » Definitions » Issuance of Debt

Theratechnologies (TSX:TH) Issuance of Debt : C$27.0 Mil (TTM As of Feb. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Theratechnologies Issuance of Debt?

Theratechnologies's Issuance of Debt for the three months ended in Feb. 2024 was C$0.0 Mil.

Theratechnologies's Issuance of Debt for the trailing twelve months (TTM) ended in Feb. 2024 was C$27.0 Mil.

Theratechnologies Issuance of Debt Historical Data

The historical data trend for Theratechnologies's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Issuance of Debt Chart

Theratechnologies Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 107.66 27.41

Theratechnologies Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 26.96 - -

Theratechnologies Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$27.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Theratechnologies Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Theratechnologies's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Theratechnologies (TSX:TH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (TSX:TH) » Definitions » Issuance of Debt
Comparable Companies
XCNQ:METX XCNQ:ACOG XCNQ:DTC TSX:ONC TSX:MSCL TSXV:MIR TSX:HBP TSX:BCT TSXV:ARCH TSX:MBX OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB XBRU:ARGX BNTX
Traded in Other Exchanges
THTX:USA TQ80:Germany
Address
2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8
Website
https://www.theratech.com
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
Executives
Joseph Arena Director
Philippe Dubuc Senior Officer
Gérald A. Lacoste Director
Paul Lévesque Senior Officer
Andrew Molson Director
Dawn Svoronos Director
John Leasure Senior Officer